Brief: KeifeRX Announces Research Collaboration & Option Agreement With Amneal Pharmaceuticals
09/01/2026 16:04
Jan 9 (Reuters) - KeifeRX: KEIFERX ANNOUNCES RESEARCH COLLABORATION AND OPTION AGREEMENT WITH AMNEAL PHARMACEUTICALS TO ADVANCE KFRX06, A BRAIN-PENETRANT LRRK2 PROGRAM FOR PARKINSON’S DISEASE KEIFERX: FINANCIAL TERMS OF AGREEMENT WERE NOT DISCLOSED Source text: ID:nBw2S77Rwa ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amneal Pharmaceuticals
See all newsUS FDA is working with manufacturers to boost estrogen patch supply amid access concerns (updated)
U.S. RESEARCH ROUNDUP- Intuit, MongoDB, Zscaler
U.S. STOCKS ON THE MOVE-Mastercard, Yum, Equinix
Amneal Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Mastercard, Starbucks, Meta